Adverse/JJ reactions/NNS caused/VBN by/IN drugs/NNS following/VBG their/PRP$ release/NN into/IN the/DT market/NN are/VBP among/IN the/DT leading/VBG causes/NNS of/IN death/NN in/IN many/JJ countries/NNS ./.
The/DT rapid/JJ growth/NN of/IN electronically/RB available/JJ health/NN related/JJ information/NN ,/, and/CC the/DT ability/NN to/TO process/VB large/JJ volumes/NNS of/IN them/PRP automatically/RB ,/, using/VBG natural/JJ language/NN processing/NN (/-LRB- NLP/NN )/-RRB- and/CC machine/NN learning/NN algorithms/NNS ,/, have/VBP opened/VBN new/JJ opportunities/NNS for/IN pharmacovigilance/NN ./.
Survey/NNP found/VBD that/IN more/JJR than/IN 70/CD percent/NN of/IN US/NNP Internet/NNP users/NNS consult/VB the/DT Internet/NN when/WRB they/PRP require/VBP medical/JJ information/NN ./.
In/IN recent/JJ years/NNS ,/, research/NN in/IN this/DT area/NN has/VBZ addressed/VBN for/IN Adverse/JJ Drug/NN Reaction/NN (/-LRB- ADR/NN )/-RRB- pharmacovigilance/NN using/VBG social/JJ media/NNS ,/, mainly/RB Twitter/NNP and/CC medical/JJ forums/NNS and/CC websites/NNS ./.
This/DT paper/NN will/MD show/VB the/DT information/NN which/WDT can/MD be/VB collected/VBN from/IN a/DT variety/NN of/IN Internet/NN data/NNS sources/NNS and/CC search/VB engines/NNS ,/, mainly/RB Google/NNP Trends/NNPS and/CC Google/NNP Correlate/NNP ./.
While/IN considering/VBG the/DT case/NN study/NN of/IN two/CD popular/JJ Major/JJ depressive/JJ Disorder/NN (/-LRB- MDD/NNP )/-RRB- drugs/NNS ,/, Duloxetine/NNP and/CC Venlafaxine/NNP ,/, we/PRP will/MD provide/VB a/DT comparative/JJ analysis/NN for/IN their/PRP$ reactions/NNS using/VBG publicly/RB -/HYPH available/JJ alternative/JJ data/NNS sources/NNS ./.
